Advanced search
Publication Cover
Journal of Chemotherapy Volume 9, 1997 - Issue sup1
Submit an article Journal homepage
4
Views
1
CrossRef citations to date
0
Altmetric
Role of Host Factors

In Vitro Antibiotic Testing and Its Relationship to Clinical Activity

Y. MoutonService Regional Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, 135 rue du Président Coty, B.P. 619 - 59208 Tourcoing, France. Tel. +33.320.694949; fax. +33.320.694615.
&
L. DubreuilService Regional Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, 135 rue du Président Coty, B.P. 619 - 59208 Tourcoing, France. Tel. +33.320.694949; fax. +33.320.694615.
Pages 93-99 | Published online: 17 Feb 2021

REFERENCES

  • Klastersky J. Febrile neutropenia. Curr Opin Oncol 1993; 5: 625-632.
  • Mouton Y. Point actuel sur les infections chez les immunodéprimés. PIL Ed. 1994: 1 vol., 120.
  • Talcott JA, Finberg R, Siegel RD. Risk assessment in cancer patients with fever and neutropenia: a prospective, two center validation of a prediction role. J Clin Oncol 1992; 10: 316-322.
  • Coyle MB, Lipsky BA. Coryneform bacteria in infectious diseases. Clinical and laboratory aspect. Clin Microbiol Rev 1990; 3: 227-246.
  • Von Graevenitz A, Clarridge JE, Bernard KA. Clinical microbiology of coryneform bacteria. Clin Microbiol Rev 1997; 10: 125-159.
  • Shinnick TM, Good RC. Mycobacterial taxonomy. Eur J Clin Microbiol Infect Dis 1994; 13: 884-901.
  • Wallace RJ. Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria. Eur J Clin Microbiol Infect Dis 1994; 13: 953-960.
  • Dahlen G, Wikstnm M, Renvert S. Treatment of periodontal disease based on microbiological diagnostic. A 5-year follow up on individual patterns. J Periodontol 1996; 67: 879-887.
  • Trexler Flessen M, Kaye D. Principles of selection and use of antibacterial agents. Infect Dis Clin N Am 1995; 9: 531-545.
  • Mac Gowan A. Concentration controlled and concentration defined clinical trials: do they offer any advantages for antimicrobial chemotherapy? J Antimicrob Chemother 1996; 37: 1-6.
  • Munckhoff WJ, Grayson ML, Turnidge JD. A metaanalysis of studies on the safety and efficacy of aminoglosides given either once daily or as divided doses. J Antimicrob Chemother 1996; 37: 645-663.
  • Mouton JW, Vinks AT. Is continuous infusion of beta-lactam antibiotics worthwhile? Efficacy and pharmacokinetic considerations. J Antimicrob Chemother 1996; 38: 5-15.
  • Anonymous. Guidelines for the clinical evaluation of anti-infective drugs. Eur Soc Clin Microbiol Infect Dis 1993; 1 vol, 354 p.
  • Beam TR, Gilbert DN, Kunin CM. General guidelines for the clinical evaluation of anti-infective drug products. Clin Infect Dis, 1992; 15 (suppl.): 5-32.
  • Mouton Y, Senneville E. Broad versus narrow spectrum antibiotic use: The role of in vitro testing and its correlation with clinical efficacy. Postgrad Med J 1992; 68 (Suppl. 3): 68-72.
  • Sirot J, Courvalin P, Soussy CJ et al. Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria. Clin Microbiol Infect 1992; 2, (suppl.1): 5-25.
  • Nagy E, Heizmann WR, Werner H. Effect of daptomycin, metronidazole and mezlocillin combinations on mixed bacterial cultures involving facultative and anaerobic bacteria. Scand J Infect Dis 1991; 23: 239-245.
  • Amsterdam D. The MIC: myth and reality. Antimicrob Newsl 1992; 8: 9-16.
  • Isenberg HD. Antimicrobial susceptibility testing: a critical evaluation. J Antimicrob Chemother 1988; 22, Suppl. A: 73-86.
  • Citron DM. Susceptibility testing of anaerobic bacteria: a review of current methods and future prospects. Antimicrob Newsl 1992; 8: 53-58.
  • Finegold SM. Clinical relevance of antimicrobial susceptibility testing. Eur J Clin Microbiol Infect Dis 1992; 11: 1021-1024.
  • Wolfson JS, Swartz MN. Serum bactericidal activity as a monitor of antibiotic therapy. N Engl J Med 1985; 312: 968-975.
  • Weinstein MP, Sratton CW, Relier LB. Current status of the serum bactericidal test as a monitor of therapeutic efficacy in serious infections. Antimicrob Newsl 1986; 3: 9-14.
  • Greenwood D. In vitro veritas? Antimicrobial susceptibility tests and their clinical relevance. J Infect Dis 1981; 144: 380-385.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.